Related references
Note: Only part of the references are listed.Spectrum of activity testing for therapeutics against all four dengue virus serotypes in AG129 mouse models: Proof-of-concept studies with the adenosine nucleoside inhibitor NITD-008
Gregg N. Milligan et al.
ANTIVIRAL RESEARCH (2018)
Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy
Alejandro Schcolnik-Cabrera et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)
ICTV Virus Taxonomy Profile: Togaviridae
Rubing Chen et al.
JOURNAL OF GENERAL VIROLOGY (2018)
Dengvaxia controversy: impact on vaccine hesitancy
Khunsha Fatima et al.
JOURNAL OF GLOBAL HEALTH (2018)
Waiting in the wings: The potential of mosquito transmitted flaviviruses to emerge
Duncan R. Smith
CRITICAL REVIEWS IN MICROBIOLOGY (2017)
Anti-Tumorigenic Potential of a Novel Orlistat-AICAR Combination in Prostate Cancer Cells
Clayton Wright et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
ICTV Virus Taxonomy Profile: Flaviviridae
Peter Simmonds et al.
JOURNAL OF GENERAL VIROLOGY (2017)
Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoes
Yang Liu et al.
NATURE (2017)
Fatty acid synthase - Modern tumor cell biology insights into a classical oncology target
Douglas Buckley et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Involvement of fatty acid synthase in dengue virus infection
Natthida Tongluan et al.
VIROLOGY JOURNAL (2017)
Progress and Works in Progress: Update on Flavivirus Vaccine Development
Matthew H. Collins et al.
CLINICAL THERAPEUTICS (2017)
Zika virus: history of a newly emerging arbovirus
Nitwara Wikan et al.
LANCET INFECTIOUS DISEASES (2016)
Lipids and flaviviruses, present and future perspectives for the control of dengue, Zika, and West Nile viruses
Miguel A. Martin-Acebes et al.
PROGRESS IN LIPID RESEARCH (2016)
The anti-obesity drug orlistat reveals anti-viral activity
Elisabeth Ammer et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2015)
Evidence of plasticity in the dengue virus: Host cell interaction
Chaiyot Rungruengphol et al.
MICROBIAL PATHOGENESIS (2015)
Structure-Function Relationships Underlying the Replication Fidelity of Viral RNA-Dependent RNA Polymerases
Grace Campagnola et al.
JOURNAL OF VIROLOGY (2015)
Fatty Acid Synthase Is a Potential Therapeutic Target in Estrogen Receptor-/Progesterone Receptor-Positive Endometrioid Endometrial Cancer
Mohammed Tanjimur Rahman et al.
ONCOLOGY (2013)
Chikungunya Virus Infection of Cell Lines: Analysis of the East, Central and South African Lineage
Nitwara Wikan et al.
PLOS ONE (2012)
Dengue Virus Infection Perturbs Lipid Homeostasis in Infected Mosquito Cells
Rushika Perera et al.
PLOS PATHOGENS (2012)
Combination of alpha-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo
Jinhong Chang et al.
ANTIVIRAL RESEARCH (2011)
Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal
Hui-Yen Chuang et al.
BIOMEDICINE & PHARMACOTHERAPY (2011)
Chikungunya in Southeast Asia: understanding the emergence and finding solutions
Rojjanaporn Pulmanausahakul et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2011)
Present and future arboviral threats
Scott C. Weaver et al.
ANTIVIRAL RESEARCH (2010)
Dengue Virus-Induced Autophagy Regulates Lipid Metabolism
Nicholas S. Heaton et al.
CELL HOST & MICROBE (2010)
Fatty acid synthase as a potential therapeutic target in cancer
Richard Flavin et al.
FUTURE ONCOLOGY (2010)
Dengue Virus Capsid Protein Usurps Lipid Droplets for Viral Particle Formation
Marcelo M. Samsa et al.
PLOS PATHOGENS (2009)
A single mutation in chikungunya virus affects vector specificity and epidemic potential
Konstantin A. Tsetsarkin et al.
PLOS PATHOGENS (2007)
Antitumoral actions of the anti-obesity drug orlistat (Xenical™) in breast cancer cells:: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene
JA Menendez et al.
ANNALS OF ONCOLOGY (2005)
Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo
K Whitby et al.
JOURNAL OF VIROLOGY (2005)
The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell
LB Talarico et al.
ANTIVIRAL RESEARCH (2005)
Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity
SJ Kridel et al.
CANCER RESEARCH (2004)
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity
DW Vaughn et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Orlistat, a new lipase inhibitor for the management of obesity
AM Heck et al.
PHARMACOTHERAPY (2000)
Share Paper
